Authors:
Sabel, MS
Levine, EG
Hurd, T
Schwartz, GN
Zielinski, R
Hohn, D
Edge, SB
Citation: Ms. Sabel et al., Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy?, AM J CL ONC, 24(4), 2001, pp. 425-428
Authors:
Kaufman, D
Raghavan, D
Carducci, M
Levine, EG
Murphy, B
Aisner, J
Kuzel, T
Nicol, S
Oh, W
Stadler, W
Citation: D. Kaufman et al., Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer, J CL ONCOL, 18(9), 2000, pp. 1921-1927
Authors:
Cotton, SP
Levine, EG
Fitzpatrick, CM
Dold, KH
Targ, E
Citation: Sp. Cotton et al., Exploring the relationships among spiritual well-being, quality of life, and psychological adjustment in women with breast cancer, PSYCHO-ONC, 8(5), 1999, pp. 429-438
Authors:
Levine, EG
Cirrincione, CT
Szatrowski, TP
Canellos, G
Norton, L
Henderson, IC
Citation: Eg. Levine et al., Phase II trial of topotecan in advanced breast cancer - A Cancer and Leukemia Group B study, AM J CL ONC, 22(3), 1999, pp. 218-222
Citation: A. Moyer et Eg. Levine, Clarification of the conceptualization and measurement of denial in psychosocial oncology research, ANN BEHAV M, 20(3), 1998, pp. 149-160